Alimera Sciences (ALIM) Misses Q3 EPS by 5c

Alimera Sciences (NASDAQ: ALIM) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $10.53 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Micron reports Q4 today: Why Lynx Equity sees massive upside
• Jefferies names top pick in India medical supplies sector
• Hermes stock target lowered at Citi on continued China weakness